Geneseal
Latest Information Update: 30 Mar 2007
At a glance
- Originator Molecular Targeting Technologies
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ischaemic heart disorders
Most Recent Events
- 13 Nov 2001 This programme is available for licensing (http://www.mtarget.com/)
- 14 Jun 2001 New profile
- 14 Jun 2001 Preclinical development for Ischaemic heart disorders in USA (Unknown route)